Home » PLAVIX SUITS HIGHLIGHT WAR OVER GENERICS
PLAVIX SUITS HIGHLIGHT WAR OVER GENERICS
The marketers of the world's second-largest-selling drug dodged a major threat to their revenues two months ago by reaching a deal to keep a generic competitor at bay until at least 2011.
The Post and Courier (http://www.charleston.net/stories/?newsID=89851§ion=business)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May